or Try an Advanced Search...

    Cellectis Stocks List

    Symbol Grade Name % Change
    PSTX D Poseida Therapeutics, Inc. -0.18
    CLLS D Cellectis S.A. -1.57
    MBIO F Mustang Bio, Inc. 0.29
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Chimeric Antigen Receptor Medicine Cancer Cancer Treatment Immune System Leukemia Solid Tumors Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Biotechnology Blastoma CD19 Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cell Product Chimeric Antigen Receptor T Cell Chronic Lymphocytic Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Cellectis stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 0.44
    IWC B iShares Microcap ETF 0.05
    RFLR D Innovator U.S. Small Cap Power Buffer ETF - September Innovator U.S. Small Cap Managed Floor ETF 0.02
    GSSC B Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0.02
    APIE D Trust for Professional Managers ActivePassive International Equity ETF 0.01
    View all Cellectis ETFs...
    Compare ETFs
    Compare GNOM to APIE Compare RFLR to APIE Compare RFLR to GSSC

        Cellectis Stocks Recent News

        Date Stock Title
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Chimeric Antigen Receptor Medicine Cancer Cancer Treatment Immune System Leukemia Solid Tumors Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Biotechnology Blastoma CD19 Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cell Product Chimeric Antigen Receptor T Cell Chronic Lymphocytic Leukemia
        Cellectis

        Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.

        More about Cellectis
        Browse All Tags